2012 Summer Meeting
Click here to go to the previous page
We Should Opt to Optimize: Strategies to Enhance Safety of Medication Use Technologies
Track:
Education Sessions (CE)
Program Code: 123-L05
Date: Wednesday, June 13, 2012
Time: 11:00 AM to 1:00 PM EST
Location:
321, Level 300
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Jared Cash,
PharmD, BCPS, Pharmacy Manager, Medication Safety,
Primary Childrens Medical Center (Intermountain)
Dr. Cash is the Pharmacy Manager of Medication Safety at Intermountain's Primary Children's Medical Center, where he has worked for the last twenty years and has co-chaired the Medication Safety Team for the last eight. He is chair of the Utah Hospital Associations Adverse Drug Event Committee and serves on the Pediatric and Neonatal Dosage Handbooks editorial advisory panel. He is also on the Board of Directors for the Pediatric Pharmacy Advocacy Group. Dr. Cash has published in the field of medication safety since 2003 and most recently co-authored with Stu Levine the pediatric chapter of Michael Cohens third edition of Medication Errors. He has worked closely with the Institute of Safe Medication Practice for over 5 years as a pediatric consultant.
|
James Hoffman,
PharmD, MS, Medication Outcomes and Safety Officer,
St. Jude Children's Research Hospital
James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer and Associate Member in Pharmaceutical Sciences at St. Jude Childrens Research Hospital in Memphis, Tennessee. At St. Jude, he leads medication use safety efforts across the hospital and conducts research focused on patient safety event detection, patient safety culture, and clinical decision support. Hoffman has been involved in a variety of patient safety and quality improvement efforts at St. Jude including development and implementation of the hospitals electronic event reporting system (EERS), patient safety culture assessment and improvement, and refinement of clinical decision support systems.
Dr. Hoffman received both his Bachelor of Science and Doctor of Pharmacy degrees from the Philadelphia College of Pharmacy. In addition, he received a Masters of Science degree in pharmacy administration from the University of Wisconsin-Madison. He also completed a residency in pharmacy administration and a fellowship in outcomes research at the University of Wisconsin Hospital and Clinics. Dr. Hoffman is a Board Certified Pharmacotherapy Specialist. He is also an Associate Professor at the University of Tennessee Health Science Center College of Pharmacy.
|
Kevin Marvin,
MS, FHIMSS, Consultant,
Kevin Marvin Consulting, LLC
Kevin Marvin is a national leader in pharmacy informatics. Kevin is Chair-elect of the ASHP Section of Informatics and Technology and received the Sections distinguished Service Award in 2008.
Mr. Marvin has been involved in pharmacy information systems for nover 30 years. He has experience in all facets of medication information technology including retail pharmacy, hospital pharmacy, software development, product management, information systems administration and consulting. His health-system experience includes University of Wisconsin Hospital and Clinics, Health Alliance of Cincinnati, Fletcher Allen Healthcare in Burlington, Vermont, The NIH Clinical Center in Bethesda, MD and Dartmouth-Hitchcock Hospital and Clinics.
Kevin has contributed chapters on safe use of technology and electronic prescribing for two books published by ASHP and APHA.
Kevin is a pharmacist with a Pharmacy degree from the University of Wisconsin-Madison, as well as a M.S. degree in Computer Science from the University of Wisconsin-Madison. His expertise is in the design, development and implementation of automation and information system tools to support safety, efficiency and profitability in the medication-use process.
|
Mr. Philip Schneider, MS, Professor and Associate Dean, University of Arizona College of Pharmacy
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
James Hoffman,
PharmD, MS, Medication Outcomes and Safety Officer,
St. Jude Children's Research Hospital
James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer and Associate Member in Pharmaceutical Sciences at St. Jude Childrens Research Hospital in Memphis, Tennessee. At St. Jude, he leads medication use safety efforts across the hospital and conducts research focused on patient safety event detection, patient safety culture, and clinical decision support. Hoffman has been involved in a variety of patient safety and quality improvement efforts at St. Jude including development and implementation of the hospitals electronic event reporting system (EERS), patient safety culture assessment and improvement, and refinement of clinical decision support systems.
Dr. Hoffman received both his Bachelor of Science and Doctor of Pharmacy degrees from the Philadelphia College of Pharmacy. In addition, he received a Masters of Science degree in pharmacy administration from the University of Wisconsin-Madison. He also completed a residency in pharmacy administration and a fellowship in outcomes research at the University of Wisconsin Hospital and Clinics. Dr. Hoffman is a Board Certified Pharmacotherapy Specialist. He is also an Associate Professor at the University of Tennessee Health Science Center College of Pharmacy.
|
Description
With the rapid implementation of medication-use technologies, many organizations strategically plan for the implementation and maintenance phases of these projects. Additional attention is needed to improve new and existing technologies to maximize their patient safety value. This session, a collaboration of the Medication Safety and Informatics Series, offers tangible strategies to optimize safety principles within medication use technology and automation systems.
- Define an approach to prioritizing and balancing optimization of current technology and implementation of new technology.
- Develop a strategy to maximize the safety value of medication use technology after implementation.
- Discuss the current state and considerations for safe design, implementation, and use of medication use technology.
- Identify practical strategies to refine clinical decision support and manage alert fatigue.